Understanding Your Diagnosis: Type A Insulin Resistance Syndrome (TAIRS)
At a Glance
Type A insulin resistance syndrome (TAIRS) is a rare INSR-related condition in which cells respond poorly to insulin, causing very high insulin levels and symptoms such as darkened skin and irregular periods. Genetic testing helps confirm the diagnosis and guide family screening.
Receiving a diagnosis of Type A Insulin Resistance Syndrome (TAIRS) often marks the end of a long and confusing journey. Many people spend years being told they have more common conditions like Polycystic Ovary Syndrome (PCOS) or standard Type 2 Diabetes [1][2]. Learning that your symptoms are actually caused by a rare genetic change can bring a complicated mix of relief—finally having an explanation—and the weight of managing a rare disease.
This page is designed to help you understand what this diagnosis means for your body and why it likely took so long to find the right answer.
What is Type A Insulin Resistance Syndrome?
Type A Insulin Resistance Syndrome is a rare genetic condition where your body’s cells cannot respond properly to insulin, the hormone that regulates blood sugar [3].
Unlike more common forms of insulin resistance that are often linked to body weight or lifestyle, TAIRS is caused by mutations in the INSR gene [1]. This gene provides the instructions for building insulin receptors—the “locks” on the outside of your cells. When insulin (the “key”) tries to open these locks to let sugar in for energy, the broken receptors cannot respond. To compensate, your pancreas pumps out massive amounts of insulin, leading to extreme hyperinsulinemia (very high levels of insulin in the blood) [4][5].
Key Features of TAIRS
While every person’s experience is unique, several features are common in this syndrome:
- Lean Body Habitus: Most people with TAIRS are not overweight and may have a naturally lean or athletic build [4].
- Puberty-Onset: Symptoms often become most noticeable around puberty, especially for females [1].
- Acanthosis Nigricans: This is a skin condition where patches of skin (usually around the neck, armpits, or groin) become dark, thick, and velvety. It is a physical sign of very high insulin levels [1][5].
- Hyperandrogenism: High insulin levels can trigger the ovaries to produce excess male hormones (androgens). This can cause hirsutism (excess facial or body hair), persistent acne, and irregular menstrual cycles [5][6].
The Diagnostic “Odyssey”
It is very common for TAIRS to be misdiagnosed initially. Because the symptoms of irregular periods, acne, and ovarian cysts overlap so closely with Polycystic Ovary Syndrome (PCOS), many patients are treated for PCOS for years [1][6].
It is important to know that TAIRS and PCOS can coexist. TAIRS may explain severe insulin resistance and androgen-related findings, but other causes, including PCOS, still require appropriate evaluation. The clue that often leads doctors to reconsider a diagnosis is when standard treatments (like birth control or typical diabetes medications) don’t work as expected, or when lab tests show insulin levels that are exceptionally high in a person who is not obese [2][7]. A clinical diagnosis is typically confirmed through genetic testing to look for the specific INSR mutation [1]. Note that a Variant of Uncertain Significance (VUS) does not definitively confirm TAIRS on its own.
Navigating the Emotional Impact
Finding out you have a rare genetic disorder can feel overwhelming. You may experience a range of emotions:
- Validation: Finally knowing that your symptoms were not caused by your diet or lifestyle, but by your genetics, can be deeply validating [8].
- Shock and Uncertainty: Because TAIRS is rare, your local doctors may not have seen it before. This can lead to fears about the future, fertility, and long-term health [8].
- Family Concerns: Since this is a genetic condition, you may worry about whether other family members are affected. Classic TAIRS is often associated with a heterozygous (single copy) pathogenic variant that can be passed down (autosomal dominant) or happen for the first time in you (de novo), though inheritance can sometimes be recessive [9][10].
Why Genetics Matter
Understanding your specific INSR mutation is helpful for several reasons. It helps your medical team predict how your condition might progress and allows for cascade screening, where your biological relatives can be tested to see if they are also at risk for early-onset diabetes or severe insulin resistance [10][11].
Even within the same family, the symptoms of TAIRS can vary greatly. One person might develop diabetes early, while another might only show signs of high insulin or irregular periods [12][13]. This variability means your care plan must be highly individualized to your specific needs and lab results [4].
Moving Forward
A diagnosis of TAIRS is a starting point, not a final destination. While managing a rare disease involves ongoing monitoring of blood sugar and hormone levels, it also gives you a clearer map for your health. You are now managing a specific, identified genetic condition with a specialized team [14].
Common questions in this guide
What is Type A insulin resistance syndrome?
How can TAIRS be told apart from PCOS?
Does a VUS in INSR confirm Type A insulin resistance syndrome?
Can Type A insulin resistance syndrome run in families?
Why can someone with TAIRS be lean?
What should be checked after a TAIRS diagnosis?
Get notified when new evidence is published on Insulin-resistance syndrome type A.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (14)
- 1
Type A insulin resistance syndrome misdiagnosed as polycystic ovary syndrome: a case report.
Lin L, Chen C, Fang T, et al.
Journal of medical case reports 2019; (13(1)):347 doi:10.1186/s13256-019-2304-4.
PMID: 31771632 - 2
Beyond PCOS: An Unusual Presentation of Type A Insulin Resistance Syndrome.
Cehic M, Milenkovic T, Todorovic S, et al.
Journal of pediatric and adolescent gynecology 2026; (39(1)):131-134 doi:10.1016/j.jpag.2025.09.013.
PMID: 41022298 - 3
New classification and diagnostic criteria for insulin resistance syndrome.
Ogawa W, Araki E, Ishigaki Y, et al.
Endocrine journal 2022; (69(2)):107-113 doi:10.1507/endocrj.EJ21-0725.
PMID: 35110500 - 4
A Case Report: Treatment, follow-up, and literature review of type A insulin resistance syndrome caused by a De Novo INSR c.3328G>C mutation.
Ji C, Zheng X, Wang Q, Chen Z
Frontiers in endocrinology 2026; (17()):1840942 doi:10.3389/fendo.2026.1840942.
PMID: 42272804 - 5
A New Mutation of the INSR Gene in a 13-Year-Old Girl with Severe Insulin Resistance Syndrome in China.
Jin J, Liang X, Wei J, Xu L
BioMed research international 2021; (2021()):8878149 doi:10.1155/2021/8878149.
PMID: 33728347 - 6
Arg1201Gln mutation of insulin receptor impairs tyrosine kinase activity and causes insulin resistance: a case report.
Ding Q, Liang M
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2020; (36(6)):558-560 doi:10.1080/09513590.2019.1707794.
PMID: 31899992 - 7
Monogenic diabetes due to an INSR mutation in a child with severe insulin resistance.
Sanderson EE, Shah M, Hooper AJ, et al.
Endocrinology, diabetes & metabolism case reports 2022; (2022()).
PMID: 35000900 - 8
A Qualitative Research Study of Experiences and Perceptions of People Living with Insulin Resistance Syndrome or Lipoatrophic Diabetes in Japan.
Yagi N, Toda A, Mitani K, et al.
Diabetes therapy : research, treatment and education of diabetes and related disorders 2023; (14(8)):1345-1356 doi:10.1007/s13300-023-01412-6.
PMID: 37289357 - 9
Homozygous Mutation in the Insulin Receptor Gene Associated with Mild Type A Insulin Resistance Syndrome: A Case Report
Hacıhamdioğlu B, Baş EG, Delil K
Journal of clinical research in pediatric endocrinology 2020; (13(1)):100-103 doi:10.4274/jcrpe.galenos.2020.2019.0213.
PMID: 32018348 - 10
Diazoxide-unresponsive Hyperinsulinemic Hypoglycaemia in a Preterm Infant with Heterozygous Insulin Receptor Gene Mutation
Poon SWY, Chung BHY, Wong MSC, Tsang AMC
Journal of clinical research in pediatric endocrinology 2025; (17(1)):115-119 doi:10.4274/jcrpe.galenos.2023.2022-12-10.
PMID: 37074094 - 11
Type A insulin resistance syndrome due to a novel heterozygous c.3486_3503del (p.Arg1163_Ala1168del) INSR gene mutation in an adolescent girl and her mother.
Koca SB, Kulali MA, Göğüş B, Demirbilek H
Archives of endocrinology and metabolism 2024; (68()):e210305.
PMID: 38289143 - 12
Hyperinsulinemic hypoglycemia due to pathogenic INSR variants: metabolic signature, phenotypic overlap, and semidominant inheritance.
Marcelino do Nascimento R, Dos Santos A, Guadagnini D, et al.
Frontiers in endocrinology 2026; (17()):1716020 doi:10.3389/fendo.2026.1716020.
PMID: 42181197 - 13
A family with type A insulin resistance syndrome caused by a novel insulin receptor mutation.
Horikawa O, Ugi S, Takayoshi T, et al.
Endocrinology, diabetes & metabolism case reports 2023; (2023(2)).
PMID: 37042492 - 14
Combination Therapy With Semaglutide and Dapagliflozin as an Effective Approach for the Management of Type A Insulin Resistance Syndrome: A Case Report.
Martínez-Montoro JI, Pinzón-Martín JL, Damas-Fuentes M, et al.
Frontiers in endocrinology 2022; (13()):838887 doi:10.3389/fendo.2022.838887.
PMID: 35498407
This page explains a Type A insulin resistance syndrome diagnosis and genetic testing for informational purposes only and does not constitute medical advice. Ask an endocrinologist or clinical geneticist to interpret your INSR result and plan care for your situation.